Stocks · News reference
Gain Therapeutics Appoints Terenzio Ignoni As COO
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Gain Therapeutics Q2 EPS $(0.11) Beats $(0.14) Estimate
Gain Therapeutics (NASDAQ:GANX) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.14) by 21.43 percent. This is a 42.11 percent increase over losses of $(0.19) per share
8-K filing — Gain Therapeutics, Inc. (GANX)
Filed: 2026-07-16 AccNo: 0001104659-26-084086 Size: 193 KB Item 8.01: Other Events